Navigation Links
New Tulane University study says diabetes at epidemic proportions in China
Date:3/24/2010

A large population-based study of diabetes in China conducted by investigators from Tulane University and their colleagues in China has concluded that the disease has reached epidemic proportions in the adult population of China. The study estimates that 92.4 million adults age 20 or older (9.7 percent of the population) have diabetes and 148.2 million adults (15.5 percent) have prediabetes, a key risk factor for the development of overt diabetes and cardiovascular disease. The results are published in the March 25 edition of The New England Journal of Medicine.

The study builds on several recent large studies in China that have documented a rapid increase in diabetes in the population. The current study administered an oral glucose tolerance test to 46,239 adults aged 20 or older from 14 provinces and municipalities throughout China in order to identify cases of previously undiagnosed diabetes. Subjects of the study who had been previously diagnosed with diabetes were identified through questioning by the study's data collectors.

Following recent rapid economic development in China, cardiovascular disease has become the leading cause of death in the county. Diabetes is a major risk factor for cardiovascular disease, and the prevalence of diabetes in China, as this study indicates, is high and increasing. Diabetes increases the risk of cardiovascular complications and premature death, and results in a massive economic burden for society.

The researchers noted a higher prevalence of diabetes among urban residents in China than among rural ones, a result consistent with observations that have been made in developing countries throughout the world. "Urbanization is associated with changes in lifestyle that lead to physical inactivity, an unhealthful diet and obesity, all of which have been implicated as contributing factors in the development of diabetes," says Dr. Jiang He, Joseph S. Copes, M.D. Chair and Professor, Department of Epidemiology, Tulane University School of Public health and Tropical Medicine and the senior author of the study.

With its very large population, China may bear a higher diabetes-related burden than any other country, assert the researchers. Especially alarming is the finding that the majority of cases of diabetes (60.7 percent) are undiagnosed and untreated. The researchers conclude that diabetes and its consequences have become a major public health crisis in China, and recommend that the country quickly develop and institute national strategies for preventing, detecting and treating diabetes in the general population.


'/>"/>

Contact: Arthur Nead
anead@tulane.edu
504-247-1443
Tulane University
Source:Eurekalert

Related medicine news :

1. Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution
2. Grand Canyon University (GCU) Creates Special Relief Fund and Raises Money for Haiti Earthquake Survivors
3. University of Toronto scholars receive prestigious New Directions Fellowships
4. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
5. Rutgers University Offers Fundamentals of Finance and Accounting Workshop at Mount Laurel, New Jersey Location Aimed at Non-Financial Managers
6. First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University
7. University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection
8. China VoIP & Digital Telecom Subsidiary, Beijing PowerUnique Technologies, Wins Virtualization Project Bid for Peking Universitys Third Hospital
9. University of Michigan scientists discover bone marrow can harbor HIV-infected cells
10. Conference on the study of contemporary spirituality next week at University of Haifa
11. Interleukin Genetics, Inc. and Stanford University Report Genetic Test Improves Weight Loss Success With Diets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Charlevoix, MI (PRWEB) , ... February 24, 2017 ... ... venue in Charlevoix, once again hosted their Military Wedding Giveaway, with the ... be hosted by Castle Farms with services generously donated from local vendors: A ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... Hollywood, CA (PRWEB) , ... February 23, 2017 , ... ... pleased to announce that they are sponsoring a raffle. Throughout the month of February, ... Winners will receive a gift card for a dinner for two at the Cheesecake ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Juan Monteverde , ... PC , a boutique securities firm headquartered at the ... , announces that a class action lawsuit has ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or ... securities between July 23, 2015 and December 30, 2016, inclusive ...
(Date:2/24/2017)... -- Directors from Pharma To Market Pty Ltd and Ador Consulting Pte ... the founding of Pharma To Market Pte Ltd, based in ... to announce their expansion into Asia with ... The company are delighted to appoint Joelle Chia , former ... based entity. Joelle brings with her an extensive business ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
Breaking Medicine Technology: